国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2012年
23期
3484-3486
,共3页
乙肝病毒标志物%HBV-DNA%HBV-M
乙肝病毒標誌物%HBV-DNA%HBV-M
을간병독표지물%HBV-DNA%HBV-M
Hepatitis B virus markers%HBV-DNA%HBV-M
目的 探讨慢性乙型肝炎乙肝病毒血清标志物检测的临床价值.方法 采用HBV-DNA定量和HBV-M模式对我院337例慢性乙型肝炎患者进行检测,对检测结果进行统计学分析处理.结果 大三阳检出率(96.1％)最高,其次为小三阳检出率(77.9％),再次为HBsAg(+)HBcAb(+)(63.9％).大三阳的检出率与HBV-DNA的含量同其他HBV-M模式相比,差异均有统计学意义(P＜ 0.05).结论 HBV-DNA和HBV-M模式的联合检测对慢性乙型肝炎患者病情早期的诊断、治疗及预后判断有一定的临床意义
目的 探討慢性乙型肝炎乙肝病毒血清標誌物檢測的臨床價值.方法 採用HBV-DNA定量和HBV-M模式對我院337例慢性乙型肝炎患者進行檢測,對檢測結果進行統計學分析處理.結果 大三暘檢齣率(96.1％)最高,其次為小三暘檢齣率(77.9％),再次為HBsAg(+)HBcAb(+)(63.9％).大三暘的檢齣率與HBV-DNA的含量同其他HBV-M模式相比,差異均有統計學意義(P＜ 0.05).結論 HBV-DNA和HBV-M模式的聯閤檢測對慢性乙型肝炎患者病情早期的診斷、治療及預後判斷有一定的臨床意義
목적 탐토만성을형간염을간병독혈청표지물검측적림상개치.방법 채용HBV-DNA정량화HBV-M모식대아원337례만성을형간염환자진행검측,대검측결과진행통계학분석처리.결과 대삼양검출솔(96.1％)최고,기차위소삼양검출솔(77.9％),재차위HBsAg(+)HBcAb(+)(63.9％).대삼양적검출솔여HBV-DNA적함량동기타HBV-M모식상비,차이균유통계학의의(P＜ 0.05).결론 HBV-DNA화HBV-M모식적연합검측대만성을형간염환자병정조기적진단、치료급예후판단유일정적림상의의
Objective To investigate the clinical value of the serum markers hepatitis B virus.Methods HBV-DNA quantification and HBV-M model were used to detect the markers in 337 patients with chronic hepatitis B from our hospital,and the results were statistically analyzed.Results The detection rate with HBsAg(+),HBeAg(+),and HBcAb(+) was 96.1％,and the detection rate with HBsAg(+),HBeAb(+),and HBcAb(+) was 77.9％,and the detection rate with HBsAg (+) and HBcAb (+) was 63.9％.The detection rate with HBsAg(+),HBeAg(+),and HBcAb(+) and HBV-DNA levels statistically differed from that of HBV-M model (P ＜ 0.05).Conclusions Combined detection of HBV DNA and HBV-M mode is clinically significant in the early diagnosis,treatment and prognosis of patients with chronic hepatitis B disease.
